Strategy Signal
420 Lexington Avenue, Suite 300, New York, NY 10170 | 646-355-0940
  November 18, 2017 Home   •   About   •   Research   •   Client Login   •   Contact
Over 25 years of experience advising investors and healthcare companies on the dynamic technology landscape and emerging trends.

Pamela Bassett has over 25 years of experience advising investors and healthcare companies on the dynamic technology landscape and how emerging trends could impact their businesses and investments. Dr. Bassett was a Partner, Managing Director and Senior Equity Analyst, Life Sciences Research with Cantor Fitzgerald, a leading global financial services firm to the institutional equity and fixed-income markets. Frequently quoted, Dr. Bassett’s views have been read in Business Week, Barron’s, The New York Times, The Boston Globe, TheStreet’s Real Money and numerous journals, industry magazines and newspapers.

Dr. Bassett was the founder and President of BioTrend Corporation which provided strategic advisory services focused on emerging technologies and business strategies, mergers, acquisitions and alliances to major multi-national healthcare companies. Dr. Bassett has worked in corporate biotechnology in-licensing/out-licensing, founded a company that developed a first-in-class integrated clinical and administrative software system used in hospitals nationwide, and founded a hospital dental clinic providing comprehensive treatment to patients with special medical needs. Dr. Bassett received her M.B.A. from Wharton Graduate School, University of Pennsylvania, completed a Residency in Anesthesiology at Drexel University College of Medicine, and received her D.M.D. from Tufts University School of Dental Medicine and B.A. in Biology from Oakland University. Dr. Bassett holds Series 7, 63, 86 and 87 FINRA licenses.